Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with Photofrin for unresectable type III or IV cholangiocarcinoma
2006-006171-20Phase 3Active
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of porfimer sodium in cholangiocarcinoma (CCA) (2 arms), sponsored by Centre Hospitalier Universitaire d'Angers. Primary endpoint: Overall survival at 1 year. Started Apr 2007; status: active.
02
Drugs
porfimer sodium
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on 2006-006171-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006171-20.